发明公开
EP2636735A4 RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES
审中-公开
新流感衍生HÄMAGGLUTININPROTEINEN的重组痘苗病毒
- 专利标题： RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES
- 专利标题（中）： 新流感衍生HÄMAGGLUTININPROTEINEN的重组痘苗病毒
-
申请号： EP11832651申请日： 2011-10-13
-
公开(公告)号： EP2636735A4公开(公告)日： 2015-05-20
- 发明人: KOHARA MICHINORI , YASUI FUMIHIKO , MURAKAMI TOSHIO , KIDA HIROSHI , SAKODA YOSHIHIRO
- 申请人： TOKYO METROPOLITAN INST MEDICAL SCIENCE , CHEMO SERO THERAPEUT RES INST , UNIV HOKKAIDO NAT UNIV CORP
- 专利权人： TOKYO METROPOLITAN INST MEDICAL SCIENCE,CHEMO SERO THERAPEUT RES INST,UNIV HOKKAIDO NAT UNIV CORP
- 当前专利权人： TOKYO METROPOLITAN INST MEDICAL SCIENCE,CHEMO SERO THERAPEUT RES INST,UNIV HOKKAIDO NAT UNIV CORP
- 优先权： JP2010233064 2010-10-15
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K31/711 ; A61K35/76 ; A61K39/145 ; A61K48/00 ; A61P31/16 ; C12N7/04
摘要：
Provided are a highly-safe recombinant vaccinia virus that is effective in preventing the onset of symptoms due to infection by novel influenza viruses, and a vaccine for the novel influenza viruses containing the recombinant vaccinia virus. This recombinant vaccinia virus is capable of expressing the hemagglutinin protein genes of the novel influenza virus. This novel influenza vaccine contains the recombinant vaccinia virus.
信息查询
IPC分类:
